India's first clean-label paediatric pharmaceutical platform — same trusted drugs, free of harmful synthetic additives.
Reformulating medicines with patent pending formulation platform technology. Starting with Cough syrups.
Most paediatric medicines use formulations built for adults — with additives that can be harmful to developing children.
Parabens, sorbitol, glycerine, PEG, synthetic dyes — standard ingredients in children's medicines flagged by 200+ studies for safety risks in neonates and infants.
US FDA, WHO, and EMA have issued guidelines restricting these additives since 2014. India's CDSCO only launched a high-risk additive tracker in October 2025.
Legacy pharma companies continue using the same formulations — cost and convenience trump safety. No Indian brand has addressed this white space.
We don't change the active ingredient — we replace every harmful excipient with a safe, biocompatible, natural alternative.
Curethic formulations contain the same clinically established active pharmaceutical ingredients used in conventional medicines, but are developed without unnecessary synthetic inactive ingredients or commonly debated excipients — including artificial sweeteners, artificial dyes, parabens, and 9+ allergens.
From trial-and-error to data-driven formulation science — our proprietary engine maps excipient-drug interactions to design optimised, safe formulations.
High-volume pediatric category with widespread use of synthetic solvents, sweeteners, dyes, and preservatives — despite repeated safety and adulteration concerns and minimal formulation innovation.
One of India's fastest-growing pediatric liquid segments, yet still dominated by sugar-heavy and excipient-loaded formulations with limited clean-label innovation.
Critical pediatric formulations where reducing unnecessary excipient exposure can meaningfully improve tolerability, compliance, and formulation quality standards.
Topical and intranasal pediatric products re-engineered to minimize harsh solvents, fragrances, dyes, and other avoidable synthetic excipients.
Built by scientists, formulation experts, and pharma strategists who understand the problem from the inside.
We're looking for pharma partners, healthcare professionals, and mission-aligned investors to build India's first clean-label paediatric pharmaceutical platform.